Mahajan Sonal, Sunsunwal Sonali, Gautam Vikas, Singh Meenu, Ramya T N C
CSIR- Institute of Microbial Technology, Sector 39A, Chandigarh, 160036, India.
Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India.
Biochem Biophys Rep. 2021 May 26;26:101028. doi: 10.1016/j.bbrep.2021.101028. eCollection 2021 Jul.
Chronic mucoid infections are a major scourge in cystic fibrosis patients. Mucoid displays structured alginate-rich biofilms that are resistant to antibiotics. Here, we have assessed the efficacy of a panel of alginate lyases in combating mucoid biofilms in cystic fibrosis. Albeit we could not demonstrate alginate degradation by alginate lyases in sputum, we demonstrate that the endotypic alginate lyases, Aly (from ) and AlyVI (from sp. QY101) and the exotypic alginate lyases, AlyFRB (from sp. alg1), and SA1-IV (from sp. A1), indeed inhibit biofilm formation by a mucoid strain isolated from the sputum of a cystic fibrosis patient with comparative effect to that of the glycoside hydrolase PslG, a promising candidate for biofilm treatment. We believe that these enzymes should be explored for in vivo efficacy in future studies.
慢性黏液样感染是囊性纤维化患者的一大祸害。黏液样菌呈现富含藻酸盐的结构化生物膜,对抗生素具有抗性。在此,我们评估了一组藻酸盐裂解酶对抗囊性纤维化患者黏液样生物膜的功效。尽管我们无法证明藻酸盐裂解酶能在痰液中降解藻酸盐,但我们证明,内型藻酸盐裂解酶Aly(来自……)和AlyVI(来自嗜温栖热放线菌属QY101)以及外型藻酸盐裂解酶AlyFRB(来自嗜温栖热放线菌属alg1)和SA1-IV(来自嗜温栖热放线菌属A1)确实能抑制从一名囊性纤维化患者痰液中分离出的黏液样菌株形成生物膜,其效果与糖苷水解酶PslG相当,PslG是生物膜治疗的一个有前景的候选药物。我们认为,这些酶在未来的研究中应探索其体内功效。